Net profit of Neurocrine Biosciences under GAAP for 9 months of 2020 amounted to $59.4 million, having increased 20 times compared to $3 million in the previous year. Revenue increased 46.7% to $798 million, against $544 million a year earlier.
Net profit of Neurocrine Biosciences under GAAP for 9 months of 2020 amounted to $59.4 million, having increased 20 times compared to $3 million in the previous year. Revenue increased 46.7% to $798 million, against $544 million a year earlier. 
neurocrine.gcs-web.com
English (US) 